Chlorogenic acid alleviates letrozole-induced polycystic ovary syndrome in mice by modulating inflammatory mediators and antioxidant signaling pathways
- 25 November 2025
- journal article
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 173, 104805
Abstract
No abstract availableKeywords
Funding Information
- Ahvaz Jundishapur University of Medical Sciences (APRC-0201)
This publication has 51 references indexed in Scilit:
- Chlorogenic acid mitigates DHEA-induced oxidative stress in granulosa cells and alleviates ferroptosis via the NF-κB signaling pathway in PCOSEuropean Journal of Pharmacology, 2025
- Association of Free Radical Product and Polycystic Ovary Syndrome: A Systematic Review and Meta-analysisReproductive Sciences, 2024
- HOMA-IR as a predictor of Health Outcomes in Patients with Metabolic Risk Factors: A Systematic Review and Meta-analysisHigh Blood Pressure & Cardiovascular Prevention, 2022
- Chlorogenic acid improves functional potential of follicles in mouse whole ovarian tissues in vitroMolecular Biology Reports, 2022
- Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in ratsBiomedicine & Pharmacotherapy, 2022
- Acupuncture regulates the autophagy of ovarian granulosa cells in polycystic ovarian syndrome ovulation disorder by inhibiting the PI3K/AKT/mTOR pathway through LncMEG3Biomedicine & Pharmacotherapy, 2021
- Advances in the molecular mechanisms of NLRP3 inflammasome activators and inactivatorsBiochemical Pharmacology, 2020
- Heme oxygenase-1/carbon monoxide as modulators of autophagy and inflammationArchives of Biochemistry and Biophysics, 2019
- Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS)Archives of Biochemistry and Biophysics, 2019
- Chlorogenic acid isomers directly interact with Keap 1-Nrf2 signaling in Caco-2 cellsMolecular and Cellular Biochemistry, 2019